Search Within

Jamie Erin Chaft

Formats
  1. Meeting Abstract (147)
  2. Journal Article (130)
  3. Review (9)
  4. Editorial (2)
  5. Miscellaneous (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (293)
  2. Solid Tumor Oncology Division (293)
  3. Thoracic Oncology (293)
  4. Surgery (114)
  5. Department of Pathology and Laboratory Medicine (98)
  6. GSK Faculty (76)

More Groups

People
  1. Mark Kris (107)
  2. Matthew Hellmann (68)
  3. Andreas Rimner (59)
  4. David Jones (50)
  5. Abraham Wu (47)
  6. Valerie Rusch (47)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (28)
  4. 2022 (23)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (60)
  2. Journal of Clinical Oncology (58)
  3. International Journal of Radiation Oncology, Biology, Physics (25)
  4. Annals of Oncology (13)
  5. Journal of Thoracic and Cardiovascular Surgery (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. American Society of Clinical Oncology (62)
  3. American Association for Cancer Research (23)
  4. Oxford University Press (16)
  5. Nature Publishing Group (12)
  6. Mosby Elsevier (10)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D. H.; Bunn, P. A.; Johnson, B. E.; Kwiatkowski, D. J.; Kris, M. G.; Wistuba, I. I.; Gandhi, M.; Phan, S.; Shames, D. S.; Schulze, K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Checkmate 816: A phase 3, randomized, open-label trial of nivolumab plus ipilimumab vs platinum doublet chemotherapy as neoadjuvant treatment for early-stage NSCLC
    Meeting Abstract

    Forde, P. M.; Chaft, J. E.; Felip, E.; Broderick, S.; Girard, N.; Awad, M. M.; Kerr, K.; Blackwood-Chirchir, A.; Yang, R.; Geese, W. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective analysis of clinical outcomes of early stage ALK-positive (ALK+) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Dagogo-Jack, I.; Santini, F.; Eng, J.; Yeap, B. Y.; Izar, B.; Chin, E.; Litvak, A.; Jones, D. R.; Kris, M. G.; Shaw, A. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • EA5142 adjuvant nivolumab in resected lung cancers (ANVIL): The newest study in the ALCHEMIST platform
    Meeting Abstract

    Chaft, J. E.; Dahlberg, S. E.; Gerber, D. E.; Oxnard, G. R.; Malik, S. M.; Simone, C. B.; Edelman, M. J.; Heymach, J.; Rudin, C. M.; Ramalingam, S. S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • SBRT and sequential chemotherapy for stage IIA to IIIA non-small cell lung cancer - A phase I dose escalation study
    Meeting Abstract

    Von Reibnitz, D.; Chaft, J.; Wu, A.; Gelblum, D.; Yorke, E.; Gelb, E.; Mitchell, S.; Ng, K.; Rimner, A.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1 selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Garassino, M.; Rizvi, N.; Besse, B.; Jänne, P.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers
    Journal Article

    Li, B. T.; Stephens, D.; Chaft, J. E.; Rudin, C. M.; Jones, D. R.; Rusch, V. W.; Rimner, A.; Isbell, J. M.
    Annals of Translational Medicine (2017)

    Fulltext@MSK | Save
  • Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiation therapy for locally advanced lung adenocarcinoma
    Meeting Abstract

    Leeman, J. E.; Shepherd, A. F.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Travis, W.; Adusumilli, P.; Jones, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Prognostic impact of tumor location and lymph node burden for patients with stage IIIA non-small cell lung cancer receiving postoperative radiation therapy
    Meeting Abstract

    Imber, B. S.; Leeman, J. E.; Shepherd, A. F.; Wild, A.; Pei, X.; Gelb, E.; Chaft, J.; Mychalczak, B. R.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save